Skip to main content
OpenTrials
Completed

NCT Number: NCT03863158

Optimal Timing of Coronary Artery Bypass Grafting in Hemodynamically Stable Patient After Myocardial Infarction and Definition of Poor Prognostic Factors. Pilot Study

Acute coronary syndromes (ACS) represent the leading cause of death in France. Their incidence is increasing due to population aging and to the persistence of cardiovascular risk factors. Currently, revascularization surgery remains outside the emergency treatment, because early performed, it tends to lead to extension and hemorrhage of the infarcted area, because of the CPB, aortic clamping, cardioplegia, and other heart manipulation.

However, CABG are indicated as an emergency in some situations of STEMI: Threat of infarction of an extended territory without favorable anatomy to angioplasty, anatomy not favorable to angioplasty associated with cardiogenic shock or persistent ischemia, acute complications of myocardial infarction (massive mitral insufficiency, interventricular communication, parietal rupture) requiring surgery under CPB with concomitant bypass surgery or failure of angioplasty (proximal coronary dissection).

Operative mortality is high; 15 to 20% for patients operated 12 to 48 hours after AMI and 4-5% for those operated after 48 hours.

Nevertheless, it seems legitimate to study if there would be a place for primary surgical revascularization in case of patient with hemodynamically stable ACS, in order to limit myocardial ischemia, spread of necrosis, to limit the risk of recurrence, and the consequences of low cardiac output. Performing a complete early surgical revascularization could limit the ischemia-reperfusion syndrome and anticipate the occurrence of cardiogenic shock.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Observational

About this study

Trial on medical records only

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients presenting acute myocardial infarction with hemodynamic stability at the diagnosis
  • Patients undergoing coronary artery bypass in Dijon University hospital

Exclusion criteria

  • Patients with Acute pulmonary oedema
  • Patients with cardiorespiratory arrest before coronary angiography
  • hemodynamically unstable patient at diagnosis
  • patients requiring combined surgery
  • patients with unstable angina

Treatment and study plan

No intervention

Other

No intervention / medical records only

Primary outcomes

  1. Correlation between the mortality rate and the delay between the surgical revascularization and the date of diagnosis of mycardial infaction in hemodynamically stable patients

    Time frame: 30 days

    Delay in days between diagnosis and surgery

Secondary outcomes

  1. Determine the predictors of intra-hospital mortality rate in hemodynamically stable patients operated of coronary bypass

    Time frame: 30 days

    Evaluate the results of evaluations carried out in patients who died compared to patients who did not die and the normal population

Sponsors and collaborators

Lead sponsor

Centre Hospitalier La Chartreuse

Other

Collaborators

  • BOUCHOT Olivier
  • LAUBRIET-JAZAYERI Aline

Registry information

Important dates

Study start
2007
Primary completion
2019
Study completion
2019
First posted
Mar 5, 2019
Registry last updated
Mar 5, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.